Cleared Traditional

Creo Electrosurgical System with NP1 Instrument (K221672) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221672 · Creo Medical, Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
250d
Days
Class 2
Risk

K221672 is an FDA 510(k) clearance for the Creo Electrosurgical System with NP1 Instrument. Classified as System, Ablation, Microwave And Accessories (product code NEY), Class II - Special Controls.

Submitted by Creo Medical, Ltd. (Chepstow, GB). The FDA issued a Cleared decision on February 14, 2023 after a review of 250 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4400 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Creo Medical, Ltd. devices

Submission Details

510(k) Number K221672 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 09, 2022
Decision Date February 14, 2023
Days to Decision 250 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
135d slower than avg
Panel avg: 115d · This submission: 250d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NEY System, Ablation, Microwave And Accessories
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Consultant

Phil Triolo and Associates LC
Phil Triolo

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NEY System, Ablation, Microwave And Accessories

All 36
Devices cleared under the same product code (NEY) and FDA review panel - the closest regulatory comparables to K221672.
Solero Microwave Tissue Ablation (MTA) System and Accessories
K223581 · AngioDynamics, Inc. · Mar 2023
Solero Microwave Tissue Ablation (MTA) System and Accessories
K221883 · AngioDynamics, Inc. · Mar 2023
SurBlate Ablation System
K223272 · Mima-Pro Scientific, Inc. · Feb 2023
NEUWAVE Microwave Ablation System and Accessories
K220472 · Neuwave Medical, Inc. · Aug 2022
Solero Microwave Tissue Ablation (MTA) System and Accessories
K213067 · AngioDynamics, Inc. · Dec 2021
Disposable Microwave Therapeutic Antennas
K201265 · Nanjing Eco Microwave System Co., Ltd. · Jul 2021